by If your GLP-1 medicine has stopped moving the scale, it doesn't automatically mean the drug has failed. Yale Medicine's Dr. Avlin Imaeda says that when a patient doesn't respond the way doctors hope, it doesn't mean someone has failed. Most people do lose weight on these drugs, but a smaller group doesn't. The causes doctors and studies name run from diet and other health conditions to side effects, other medicines and genetics.
Disclosure: Before you read on, this page contains affiliate links. Buying through them may earn us a commission.
Is it a plateau, non-response, or a drug that's worn off?
Doctors use different words for different situations, and the difference changes what happens next. The Houston Methodist plateau article lists three. A plateau is when weight loss that was steady slows or stops. Dr. Vadim Sherman describes it as losing one to two pounds a week and then going a month without losing anything, and says that in many cases the medication hasn't stopped working.
Non-response is different. These are people who don't get meaningful weight loss despite consistent use. Houston Methodist says some see little or no change in appetite or hunger, while others notice some effect but still fall short. The third situation is tolerance, where the medicine seems to lose its effect over time. Houston Methodist notes that this often isn't tolerance in the traditional sense, but a shift in how the body responds as weight comes off.
| Term | What it means in the sources | Source |
|---|---|---|
| Plateau | Weight loss slows or stops after an early period of progress; often not a sign the drug has stopped working | Houston Methodist plateau article |
| Non-response | No meaningful weight loss despite consistent use. Some people see little or no change in appetite, while others notice some effect but still fall short | Houston Methodist plateau article |
| Tolerance | The medicine seemed to work at first but no longer has the same effect | Houston Methodist plateau article |
| Misaligned expectations | The result is real, but it falls short of a personal goal or target weight | Houston Methodist plateau article |
Yale Medicine defines a meaningful result as losing at least 5% of starting body weight. Its clinicians say many patients measure success against a 10% goal, and that a smaller loss can still bring health benefits. The Yale Medicine nonresponder article is a good place to see how these definitions get used in practice.
Quick facts on GLP-1 non-response, as of 2026-11-14
| Point | What the source says | Source |
|---|---|---|
| Meaningful benefit | Losing at least 5% of starting body weight | Yale Medicine nonresponder article |
| Share who don't reach 5% | Roughly 10% to 15% across major semaglutide and tirzepatide studies | Yale Medicine nonresponder article |
| Share with little or no loss | Yale Medicine quotes a doctor saying about 10% of trial patients see little to no weight loss | Yale Medicine nonresponder article |
| Real-world cohort | Of 483 patients, 17.8% lost less than 5% of body weight, 48.4% lost 5% to 15%, and 33.8% lost more than 15% | BMJ Open cohort analysis, published January 15, 2025 |
| Genetic variants | Carried by roughly 10% of the general population; linked to GLP-1 resistance | Stanford Medicine news release, study published April 10 in Genome Medicine |
| Weight regain | A 2022 trial found people regained two-thirds of their weight within a year of stopping 2.4 mg weekly semaglutide | Healthline GLP-1 article |
| Time before judging | “Ideally, give the medication at least 12 weeks to see an effect” | Healthline GLP-1 article |
| Stopping guidance | If you haven't lost at least 5% of starting weight after 12 weeks on the full dose, your clinician will probably advise stopping | NIDDK prescription medication guide, last reviewed June 2024 |
Why doesn't GLP-1 work for some people?
There isn't one cause. Several factors show up in the sources, and they often overlap.
Diet, activity and daily habits
Yale Medicine's Dr. Avlin Imaeda says the first step is to look at your diet. Some people still drink soda or eat fast food, which can make them feel sick or limit how well the medication works. Houston Methodist says the medicine mainly affects hunger, so weight loss still depends on how that translates into daily eating and activity.
Exercise matters too. A 2024 eClinicalMedicine (Lancet) study, as summarized by BBC Science Focus, found that GLP-1s plus supervised exercise gave more weight loss and better maintenance than drugs alone. The weight loss and appetite control guide covers how hunger and daily habits work together.
Other health conditions
Dr. Imaeda says thyroid disorders can disrupt metabolism, and she checks blood sugar control with hemoglobin A1C. People with impaired glucose regulation, including diabetes, tend to lose less weight on these medicines. Healthline's experts also name hypothyroidism, sleep apnea and chronic insomnia as conditions that can interfere with weight loss, and binge eating disorder as another factor.
Other medicines
Dr. Michael Glickman, quoted by Healthline, says some antidepressants and beta blockers that promote weight gain can make it harder to lose weight while on a GLP-1. Healthline's experts encourage you to tell your provider about every medicine you take before starting, and if you aren't losing weight.
Side effects and stopping early
BBC Science Focus reports that in one NEJM trial, 74.2% of participants on GLP-1 drugs had nausea, diarrhoea or vomiting, and 4.5% stopped because symptoms were severe. Healthline quotes Dr. Meghan Garcia-Webb saying side effects often ease, but if they are severe, some patients decide it isn't worth it. Missing doses, or stopping before the drug has had time to work, can also limit results.
Genetics and biology
Stanford Medicine researchers describe a GLP-1 resistance linked to two variants in an enzyme called PAM. In a meta-analysis of three diabetes trials with 1,119 participants, people with these variants were less responsive to the drugs. Stanford's team says it is not clear whether the variants affect weight loss from drugs like Ozempic and Wegovy, and the weight data it found was too limited to be conclusive. Dr. Imaeda says genetic effects identified so far appear modest and don't fully explain the range of responses in practice.
Sex, age and body size
A BMJ Open cohort study of 483 patients found that being a woman was associated with hyper-response (losing more than 15% of body weight) compared with non-response, with an odds ratio of 1.92. The authors note the confidence interval was quite broad, with a p value of 0.048, and that the study was run at a single obesity centre, so it shows an association rather than a cause.
Dr. Imaeda says women tend to lose more weight than men on these medicines, though she says why isn't fully understood. Yale Medicine says patients who don't respond often have a BMI above 40, a group that has been underrepresented in many GLP-1 studies.
What the head-to-head trial found: tirzepatide vs semaglutide
The clearest comparison comes from SURMOUNT-5, a randomized phase 3b trial published in the New England Journal of Medicine in May 2025. Weill Cornell Medicine's release describes the results, and the trial was sponsored by Eli Lilly, which makes tirzepatide.
| Measure over 72 weeks | Tirzepatide | Semaglutide |
|---|---|---|
| Average body-weight loss | About 20.2% | About 13.7% |
| Losing at least 25% of body weight | 32% | 16% |
| Nausea | About 44% | About 44% |
The trial enrolled 751 adults with obesity and no type 2 diabetes, and it was not blinded. The Weill Cornell Medicine trial release also notes that some people respond to neither drug. Its principal investigator is a paid consultant for Lilly and an advisory board member for Novo Nordisk.
What can be tried when GLP-1 stops working?
Your prescriber decides any change. Here's what the sources say doctors consider.
Start with the basics. Dr. Imaeda says she looks at diet, thyroid function and blood sugar first. Houston Methodist says doctors ask whether everything else, including diet and activity, is optimized. Teladoc's article says your doctor can look at other factors that may interfere with weight loss and adjust the dose.
If the result is still limited at the highest available doses, Dr. Imaeda says she might add a different medication, such as phentermine-topiramate, bupropion (Wellbutrin) or metformin. She often switches patients from Wegovy to Zepbound if possible, because Zepbound is more effective in her practice and in randomized controlled trials. Houston Methodist says increasing the dose, switching medications or combining approaches can sometimes lead to additional progress.
For some people, moving beyond medication is the next step. Yale Medicine says weight-loss surgery, such as gastric sleeve or gastric bypass, leads to greater average weight loss than medication alone, for those who qualify. Houston Methodist says bariatric surgery often leads to weight loss of about 25% to 30% or more of total body weight. The best weight loss plan for you page is a useful next read if you're weighing the options.
What's still unknown
Stanford Medicine's Dr. Anna Gloyn says the mechanism behind GLP-1 resistance remains unresolved, and it is likely complex and multifactorial. Yale Medicine says the reason women respond better isn't fully understood, and calls the hormone explanation a theory. Houston Methodist describes retatrutide as one of the newer therapies in development that aim to target three hormone pathways at once, and says responses vary from one person to another. For the numbers from its studies, see retatrutide trial results. Yale Medicine says newer, higher-dose medications that are not yet FDA-approved may be effective for nonresponders.
Questions to bring to your prescriber or pharmacist
- Have I been on the full dose for 12 weeks, and have I lost at least 5% of my starting weight?
- Have my thyroid and blood sugar been checked?
- Are any of my other medicines known to promote weight gain?
- Am I taking the medicine exactly as prescribed, including timing and dose?
- Is a different medication, a higher dose, or surgery a reasonable next option for me?
- What will it cost each month, and what does my coverage include?
By the New Life Wellness Guide Editorial Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.